AZTA Stock Analysis: Buy, Sell, or Hold?
AZTA - Azenta, Inc.
$37.40
0.89 (2.44%)
▲
5d:
+12.04%
30d:
+32.16%
90d:
+91.4%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When AZTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AZTA is 10.5% above its trading range ($33.85). Market expects 22.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AZTA is 10.5% above its trading range ($33.85). Market expects 22.2% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$28.72
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$17.84
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AZTA is currently trading at $37.40, which is considered extended relative to its 30-day fair value range of $27.25 to $33.85. From a valuation perspective, the stock is trading at a premium (Forward PE: 63.4) compared to its historical average (34.7). At these levels, the market is pricing in 22.2% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, AZTA is in a uptrend. The price is approaching resistance at $37.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AZTA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AZTA is in a uptrend. The price is approaching resistance at $37.49. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AZTA scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$27.25 -
$33.85
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
28.8%
Protect Your Profits
AZTA is technically overbought (RSI 79). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+10.5% above its trading range)
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($34.80)
- NEUTRAL: PE elevated vs history but 22.2% growth expectation is conservative given 8778% recent growth
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$27.25 -
$33.85
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.97
(7.9%)
Support & Resistance Levels
Support Level
$31.77
Resistance Level
$37.49
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
63.39
Wall Street Target
$34.80
(-7.0%)
Revenue Growth (YoY)
12.0%
Earnings Growth (YoY)
8777.8%
Profit Margin
-20.0%
Valuation Premium vs History
+22.2% premium
PE vs Historical
63.4 vs 34.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+22.2%
(market-implied from PE analysis)
1-Year Target
$45.70
(+22%)
2-Year Target
$55.85
(+49%)
3-Year Target
$68.25
(+83%)
3-Yr Target (if PE normalizes)
(PE: 63→35)
PE COMPRESSION
$37.36
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 63.4, Growth: 59.5%)
$126.22
(+238%)
Base:
(SPY PE: 20.1, Growth: 59.5%)
$39.96
(+7%)
Bear:
(PE: 17.1, Growth: 59.5%)
$33.97
(-9%)
Share & Embed Analysis
Last updated: August 23, 2026 9:47 PM ET
Data refreshes hourly during market hours. Next update: 10:47 PM
Data refreshes hourly during market hours. Next update: 10:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AZTA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Gilbert Ray Cisneros, Jr.
BUY
2026-03-03
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$85 | 37 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$246 | 41 HOLD |
Advanced AZTA Option Strategies
Professional options setups generated by AI based on today's AZTA price and gamma walls.
